Cancer feature: cnaPANCAN212

AARS2 ABCC10 APOBEC2 BYSL C6orf132 C6orf223 C6orf226 CAPN11 CCND3 CDC5L CLIC5 CNPY3 CRIP3 CUL7 CUL9 DLK2 DNPH1 FOXP4 FRS3 GLTSCR1L GNMT GTPBP2 GUCA1A GUCA1B HSP90AB1 KLC4 KLHDC3 LRFN2 LRRC73 MAD2L1BP MDFI MEA1 MED20 MRPL14 MRPL2 MRPS10 MRPS18A NCR2 NFKBIE NFYA OARD1 PEX6 PGC POLH POLR1C PPP2R5D PRICKLE4 PRPH2 PTCRA PTK7 RP1-139D8.6 RP11-444E17.6 RPL7L1 RRP36 RSPH9 RUNX2 SLC22A7 SLC29A1 SLC35B2 SPATS1 SRF SUPT3H TAF8 TBCC TCTE1 TFEB TJAP1 TMEM151B TMEM63B TOMM6 TREM1 TREM2 TREML1 TREML2 TREML4 TRERF1 TSPO2 TTBK1 UBR2 UNC5CL USP49 VEGFA XPO5 YIPF3 ZNF318

Known Driver Genes: None

Copy number alternation: gain

THR-101

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer